BioCentury | Jan 12, 2017
Company News

GeneCentric, Bristol-Myers Squibb deal

...GeneCentric Diagnostics Inc. , Durham, N.C. Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Business: Cancer Nora Weintraub Opdivo Bristol-Myers Squibb Co. GeneCentric Diagnostics Inc....
BioCentury | Jul 28, 2014
Financial News

GeneCentric Diagnostics completes venture financing

GeneCentric Diagnostics Inc. , Durham, N.C. Business: Diagnostic Date completed: 2014-07-11 Type: Venture financing Raised: $5 million Note: The company raised $5 million, according to an SEC filing. WIR Staff Diagnostic...
BioCentury | Feb 11, 2013
Emerging Company Profile

GeneCentric: Cancer sign-off

...American Society of Clinical Oncology (ASCO), Alexandria, Va. Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. GeneCentric Diagnostics Inc....
BioCentury | Sep 3, 2012
Company News

GeneCentric Diagnostics, University of North Carolina deal

...final validation testing of the Lung Subtype Platform technology. The company declined to provide details. GeneCentric Diagnostics Inc....
BioCentury | Jan 30, 2012
Financial News

GeneCentric Diagnostics completes venture financing

GeneCentric Diagnostics Inc. , Durham, N.C. Business: Diagnostic Date completed: 9/2/11 Type: Venture financing Raised: $250,000 Investor: Hatteras Venture Partners WIR Staff Diagnostic...
BioCentury | Jan 24, 2012
Financial News

GeneCentric Diagnostics debuts

...Molecular diagnostic company GeneCentric Diagnostics Inc. (Durham, N.C.) said it raised $250,000 from Hatteras Venture Partners last September...
Items per page:
1 - 6 of 6
BioCentury | Jan 12, 2017
Company News

GeneCentric, Bristol-Myers Squibb deal

...GeneCentric Diagnostics Inc. , Durham, N.C. Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Business: Cancer Nora Weintraub Opdivo Bristol-Myers Squibb Co. GeneCentric Diagnostics Inc....
BioCentury | Jul 28, 2014
Financial News

GeneCentric Diagnostics completes venture financing

GeneCentric Diagnostics Inc. , Durham, N.C. Business: Diagnostic Date completed: 2014-07-11 Type: Venture financing Raised: $5 million Note: The company raised $5 million, according to an SEC filing. WIR Staff Diagnostic...
BioCentury | Feb 11, 2013
Emerging Company Profile

GeneCentric: Cancer sign-off

...American Society of Clinical Oncology (ASCO), Alexandria, Va. Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. GeneCentric Diagnostics Inc....
BioCentury | Sep 3, 2012
Company News

GeneCentric Diagnostics, University of North Carolina deal

...final validation testing of the Lung Subtype Platform technology. The company declined to provide details. GeneCentric Diagnostics Inc....
BioCentury | Jan 30, 2012
Financial News

GeneCentric Diagnostics completes venture financing

GeneCentric Diagnostics Inc. , Durham, N.C. Business: Diagnostic Date completed: 9/2/11 Type: Venture financing Raised: $250,000 Investor: Hatteras Venture Partners WIR Staff Diagnostic...
BioCentury | Jan 24, 2012
Financial News

GeneCentric Diagnostics debuts

...Molecular diagnostic company GeneCentric Diagnostics Inc. (Durham, N.C.) said it raised $250,000 from Hatteras Venture Partners last September...
Items per page:
1 - 6 of 6